Literature DB >> 7390612

Human macrophage activation factors. I. Multiple molecular species of MAF produced by a human lymphoid cell line.

M C McDaniel.   

Abstract

The lymphokine, macrophage activation factor (MAF), is defined functionally as the factor that activates mouse macrophages to kill syngeneic tumor cells. The source of MAF in this study is the Namalwa cell line, a human Burkitt's lymphoma cell line, that produces MAF as a constitutive product. The initial procedure in MAF characterization has been chromatography on Sepharose 6B-C1 column with the denaturating solvent, 6 M guanidine HCl, pH 8.0, in order to reduce the copurification of MAF activity with serum proteins. Namalwa cells incubated in RPMI 1640 with 2% fetal calf serum (FCS) produce MAF in the molecular weight ranges of 70,000 +/- 7000, 25,000 +/- 25000, 12,500 +/- 1250 and less than 10,000; while Namalwa cells, incubated in 10% FCS, produce activity at 12,500 daltons and below. The MAF active fraction from 10% FCS supernatant was reincubated in 10% FCS for 24 hr, and on rechromatography the MAF activity appears from 70,000 to 12,500. Reincubation in 6 M guanidine moves the MAF activity to the column void volume (greater than 100,000 daltons) and to 70,000 daltons. The increase in molecular size of MAF suggests that MAF consits of a small basic molecular unit (less than 10,000 daltons) which associates in larger molecular forms upon incubation at 37 degrees C.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7390612     DOI: 10.1007/bf00914109

Source DB:  PubMed          Journal:  Inflammation        ISSN: 0360-3997            Impact factor:   4.092


  14 in total

1.  Studies on the effect of soluble lymphocyte products (lymphokines) on macrophage physiology. I. Early changes in enzyme activity and permeability.

Authors:  L W Poulter; J L Turk
Journal:  Cell Immunol       Date:  1975-11       Impact factor: 4.868

2.  Production of human lymphoblastoid interferon.

Authors:  H Strander; K E Mogensen; K Cantell
Journal:  J Clin Microbiol       Date:  1975-01       Impact factor: 5.948

3.  Amounts of Epstein-Barr virus DNA in somatic cell hybrids between burkitt lymphoma-derived cell lines.

Authors:  M Andersson
Journal:  J Virol       Date:  1975-11       Impact factor: 5.103

4.  Characterization of the effects of endotoxin on macrophage tumor cell killing.

Authors:  J B Weinberg; H A Chapman; J B Hibbs
Journal:  J Immunol       Date:  1978-07       Impact factor: 5.422

5.  Chemical characterization of products of activated lymphocytes.

Authors:  C Sorg; W Klinkert
Journal:  Fed Proc       Date:  1978-11

6.  Characterization of lymphocyte-activating factor (LAF) produced by human mononuclear cells: biochemical relationship of high and low molecular weight forms of LAF.

Authors:  A Togawa; J J Oppenheim; S B Mizel
Journal:  J Immunol       Date:  1979-05       Impact factor: 5.422

7.  Sensitivity of Epstein-Barr virus (EBV) producer and non-producer human lymphoblastoid cell lines to superinfection with EB-virus.

Authors:  G Klein; L Dombos; B Gothoskar
Journal:  Int J Cancer       Date:  1972-07-15       Impact factor: 7.396

8.  Functional and morphologic characteristics of interferon-treated macrophages.

Authors:  R M Schultz; M A Chirigos; U I Heine
Journal:  Cell Immunol       Date:  1978-01       Impact factor: 4.868

9.  Mechanism of a reaction in vitro associated with delayed-type hypersensitivity.

Authors:  B R Bloom; B Bennett
Journal:  Science       Date:  1966-07-01       Impact factor: 47.728

10.  Alterations of macrophage functions by mediators from lymphocytes.

Authors:  C F Nathan; M L Karnovsky; J R David
Journal:  J Exp Med       Date:  1971-06-01       Impact factor: 14.307

View more
  1 in total

1.  Production of macrophage activation factors by tryptic cleavage of calf serum proteins.

Authors:  M C McDaniel; M A Tucker; D A Johnson
Journal:  Inflammation       Date:  1983-12       Impact factor: 4.092

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.